Intec Pharma partners for manufacture of ‘accordion pill’ for Parkinson’s disease

Intec Pharma (NSDQ:NTEC) plans to partner with LTS to manufacture the company’s lead product candidate – an oral pill for Parkinson’s disease formulated with Intec’s “Accordion Pill” drug delivery tech.

According to the terms of the deal, LTS will manufacture the carbidopa/levodopa capsules using Intec’s production technology in LTS’ manufacturing facility in Germany.

Get the full story at our sister site, Drug Delivery Business News.

The post Intec Pharma partners for manufacture of ‘accordion pill’ for Parkinson’s disease appeared first on MassDevice.

from MassDevice http://ift.tt/2DoJnFQ